Enhancing postmarketing surveillance: continuing challenges

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 615-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002

By Bottone Frank G.   Barry William T.  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1535-1550

Informa Healthcare

Access to resources Recommend Favorite

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

By  

International Journal of Healthcare Information Systems and Informatics (IJHISI), Vol. 2, Iss. 3, 2007-07 ,pp. : 65-80

IGI Global_journal

Access to resources Recommend Favorite

Enhancing regional capacity in chronic disease surveillance in the Americas

By Choi Bernard C.K.   Corber Stephen J.   McQueen David V.   Bonita Ruth   Zevallos Juan C.   Douglas Kathy A.   Barceló Alberto   Gonzalez Miguel   Robles Sylvia   Stachenko Sylvie   Hall Mary   Champagne Beatriz M.   Lindner M. Cristina   de Salazar Ligia M.   Granero Ricardo   Soto de Laurido Lourdes E.   Lum Washington   Torres Rogger E.   Warren Charles W.   Mokdad Ali H.  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 17, Iss. 2, 2005-02 ,pp. : 130-141

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Transdermal buprenorphine in clinical practice – a post-marketing surveillance study in 13 179 patients

By Griessinger Norbert   Sittl Reinhard   Likar Rudolf  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1147-1156

Informa Healthcare

Access to resources Recommend Favorite